HONG KONG -- Shares of Angelalign Technology nearly tripled in price in the debut of China's version of Invisalign in Hong Kong on Wednesday, a performance that may put to rest concerns the city's IPO market was running out of steam.
Shares in Angelalign climbed as high HK$490 from their issue price of HK$173. The shares ultimately closed at HK$400.20, marking the best first day for a Hong Kong initial public offering of at least $100 million since Chinese colorectal cancer screening company New Horizon Health's 215% gain in February.
